Atlas Trials

Ovarian Endometrioid Tumor

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Endometrioid Tumor

RecordFirmDate
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer (NCT05226507)Nuvectis Pharma, Inc.2021-12-31
Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer (NCT04510584)University Health Network, Toronto2021-07-16
Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03685695)Roswell Park Cancer Institute2017-06-27
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02627443)National Cancer Institute (NCI)2017-05-16
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02446600)National Cancer Institute (NCI)2016-03-28
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer (NCT02520115)Barbara Ann Karmanos Cancer Institute2015-08-01

Track Ovarian Endometrioid Tumor automatically

Every clearance here is in the API, with alerts when new ones post.